-
1
-
-
29544433982
-
First-inhuman study of the Endeavor ABT-578-eluting phosphorylcholine- encapsulated stent system in de novo native coronary artery lesions: Endeavor I Trial
-
Meredith IT, Ormiston J, Whitbourn R, Kay IP, Muller D, Bonan R, Popma JJ, Cutlip DE, Fitzgerald P, Prpic R, Kuntz RE. First-inhuman study of the Endeavor ABT-578-eluting phosphorylcholine-encapsulated stent system in de novo native coronary artery lesions: Endeavor I Trial. EuroIntervention. 2005;1:157-64.
-
(2005)
EuroIntervention
, vol.1
, pp. 157-164
-
-
Meredith, I.T.1
Ormiston, J.2
Whitbourn, R.3
Kay, I.P.4
Muller, D.5
Bonan, R.6
Popma, J.J.7
Cutlip, D.E.8
Fitzgerald, P.9
Prpic, R.10
Kuntz, R.E.11
-
2
-
-
70350020760
-
Clinical and Angiographic Results with the Next-Generation Resolute Stent System: A Prospective, Multicenter, First-in-Human Trial
-
RESOLUTE Investigators
-
Meredith I, Worthley S, Whitbourn R, Walters D, McClean D, Horrigan M, Popma J, Cutlip D, DePaoli A, Negoita M, Fitzgerald P; RESOLUTE Investigators. Clinical and Angiographic Results With the Next-Generation Resolute Stent System: A Prospective, Multicenter, First-in-Human Trial. JACC Cardiovasc Interv. 2009;2:977-985.
-
(2009)
JACC Cardiovasc Interv
, vol.2
, pp. 977-985
-
-
Meredith, I.1
Worthley, S.2
Whitbourn, R.3
Walters, D.4
McClean, D.5
Horrigan, M.6
Popma, J.7
Cutlip, D.8
DePaoli, A.9
Negoita, M.10
Fitzgerald, P.11
-
3
-
-
77957255556
-
Micro-computed tomographic assessment following extremely oversized partial postdilation of drug-eluting stents
-
Basalus M, Van Houwelingen G, Ankone M, Feijen J, Von Birgen C. Micro-computed tomographic assessment following extremely oversized partial postdilation of drug-eluting stents. EuroIntervention, 2010;6:141-148.
-
(2010)
EuroIntervention
, vol.6
, pp. 141-148
-
-
Basalus, M.1
Van Houwelingen, G.2
Ankone, M.3
Feijen, J.4
Von Birgen, C.5
-
4
-
-
6944237687
-
Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy
-
DOI 10.1016/S0140-6736(04)17275-9, PII S0140673604172759
-
McFadden EP, Stabile E, Regar E, Cheneau E, Ong AT, Kinnaird T, Suddath WO, Weissman NJ, Torguson R, Kent KM, Pichard AD, Satler LF, Waksman R, Serruys PW. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet. 2004;364:1519-1521. (Pubitemid 39410418)
-
(2004)
Lancet
, vol.364
, Issue.9444
, pp. 1519-1521
-
-
McFadden, E.P.1
Stabile, E.2
Regar, E.3
Cheneau, E.4
Ong, A.T.L.5
Kinnaird, T.6
Suddath, W.O.7
Weissman, N.J.8
Torguson, R.9
Kent, K.M.10
Pichard, A.D.11
Satler, L.F.12
Waksman, R.13
Serruys, P.W.14
-
5
-
-
62849102316
-
A Qualitative and Quantitative Angiographic Analysis of Stent Fracture Late Following Sirolimus-Eluting Stent Implantation
-
Popma J, Tiroch K, Almonacid A, Cohen S, Kandzari D, Leon M. A Qualitative and Quantitative Angiographic Analysis of Stent Fracture Late Following Sirolimus-Eluting Stent Implantation. AJC. 2009;103:923-929.
-
(2009)
AJC
, vol.103
, pp. 923-929
-
-
Popma, J.1
Tiroch, K.2
Almonacid, A.3
Cohen, S.4
Kandzari, D.5
Leon, M.6
-
6
-
-
34247131800
-
Strut fracture of DES: An increasing problem?
-
DOI 10.1016/j.ijcard.2006.12.064, PII S0167527307003786
-
Jin X, Zhang S, Xie H, Wang C, Fan Z, Zeng Y, Shen Z, Fang Q. Strut fracture of DES: An increasing problem? Int J Cardiol, 2007;118:e54-e56. (Pubitemid 46601675)
-
(2007)
International Journal of Cardiology
, vol.118
, Issue.2
-
-
Jin, X.1
Zhang, S.2
Xie, H.3
Wang, C.4
Fan, Z.5
Zeng, Y.6
Shen, Z.7
Fang, Q.8
-
7
-
-
0026393462
-
Myocardial stunning due to simultaneous multivessel coronary spasms: A review of 5 cases
-
Dote K, Sato H, Tateishi H, Uchida T, Ishihara M.Myocardial stunning due to simultaneous multivessel coronary spasms: a review of 5 cases. J Cardiol. 1991;21:203-214.
-
(1991)
J Cardiol
, vol.21
, pp. 203-214
-
-
Dote, K.1
Sato, H.2
Tateishi, H.3
Uchida, T.4
Ishihara, M.5
-
8
-
-
33845337615
-
Comparison of Zotarolimus-Eluting and Sirolimus-Eluting Stents in Patients With Native Coronary Artery Disease. A Randomized Controlled Trial
-
DOI 10.1016/j.jacc.2006.08.035, PII S0735109706023503
-
Kandzari DE, Leon MB, Popma JJ, Fitzgerald PJ, O'Shaughnessy C, Ball MW, Turco M, Applegate R, Gurbel P, Midei M, Badre S, Mauri L, Thompson K, LeNarz L, Kuntz R for the ENDEAVOR III Investigators. Comparison of zotarolimus-eluting and sirolimus-eluting stents in patients with native coronary artery disease: a randomized controlled trial. J Am Coll Cardiol. 2006;48:2440-2447. (Pubitemid 44881222)
-
(2006)
Journal of the American College of Cardiology
, vol.48
, Issue.12
, pp. 2440-2447
-
-
Kandzari, D.E.1
Leon, M.B.2
Popma, J.J.3
Fitzgerald, P.J.4
O'Shaughnessy, C.5
Ball, M.W.6
Turco, M.7
Applegate, R.J.8
Gurbel, P.A.9
Midei, M.G.10
Badre, S.S.11
Mauri, L.12
Thompson, K.P.13
LeNarz, L.A.14
Kuntz, R.E.15
-
9
-
-
75249100540
-
A randomized comparison of the ENDEAVOR zotarolimus-eluting stent versus the TAXUS paclitaxel-eluting stent in de novo native coronary lesions: 12-Month outcomes from the ENDEAVOR IV trial
-
for the ENDEAVOR IV Investigators
-
Leon MB, Mauri L,Popma JJ, Cutlip DE, Nikolsky E, O'Shaughnessy C, Overlie PA, McLaurin BT, Solomon SL, Douglas JS, Ball MW, Caputo RP, Jain A, Tolleson TR, Reen BM, Kirtane AJ, Fitzgerald PJ, Thompson K, Kandzari DE, for the ENDEAVOR IV Investigators. A randomized comparison of the ENDEAVOR zotarolimus-eluting stent versus the TAXUS paclitaxel-eluting stent in de novo native coronary lesions: 12-month outcomes from the ENDEAVOR IV trial. J Am Coll Cardiol 2010;55:543-54.
-
(2010)
J Am Coll Cardiol
, vol.55
, pp. 543-554
-
-
Leon, M.B.1
Mauri, L.2
Popma, J.J.3
Cutlip, D.E.4
Nikolsky, E.5
O'Shaughnessy, C.6
Overlie, P.A.7
McLaurin, B.T.8
Solomon, S.L.9
Douglas, J.S.10
Ball, M.W.11
Caputo, R.P.12
Jain, A.13
Tolleson, T.R.14
Reen, B.M.15
Kirtane, A.J.16
Fitzgerald, P.J.17
Thompson, K.18
Kandzari, D.E.19
-
10
-
-
77950300349
-
Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): A randomized controlled superiority trial
-
SORT OUT III study group
-
Rasmussen K, Maeng M, Kaltoft A, Thayssen P, Kelbaek H, Tilsted HH, Abildgaard U, Christiansen EH, Engstrøm T, Krusell LR, Ravkilde J, Hansen PR, Hansen KN, Abildstrøm SZ, Aarøe J, Jensen JS, Kristensen SD, Bøtker HE, Madsen M, Johnsen SP, Jensen LO, Sørensen HT, Thuesen L, Lassen JF; SORT OUT III study group. Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): A randomized controlled superiority trial. Lancet. 2010;375:1090-1099.
-
(2010)
Lancet
, vol.375
, pp. 1090-1099
-
-
Rasmussen, K.1
Maeng, M.2
Kaltoft, A.3
Thayssen, P.4
Kelbaek, H.5
Tilsted, H.H.6
Abildgaard, U.7
Christiansen, E.H.8
Engstrøm, T.9
Krusell, L.R.10
Ravkilde, J.11
Hansen, P.R.12
Hansen, K.N.13
Abildstrøm, S.Z.14
Aarøe, J.15
Jensen, J.S.16
Kristensen, S.D.17
Bøtker, H.E.18
Madsen, M.19
Johnsen, S.P.20
Jensen, L.O.21
Sørensen, H.T.22
Thuesen, L.23
Lassen, J.F.24
more..
-
12
-
-
77954392890
-
Comparison of Zotarolimus-Eluting and Everolimus-Eluting Coronary Stents
-
Serruys PW, Silber S, Garg S, Jan van Geuns R, Richardt G, Buszman P, Kelbaek H, Van Boven A, Hofma S, Linke A, Klauss V, Wijns W, Macaya C, Garot P, DiMario C, Manoharan G, Kornowki R, Ischinger T, Bartorelli A, Ronden J, Bressers M, Gobbenns P, Negoita M, van Leeuwen F, Windecker S. Comparison of Zotarolimus-Eluting and Everolimus-Eluting Coronary Stents. N Engl J Med. 2010;363:136-146.
-
(2010)
N Engl J Med
, vol.363
, pp. 136-146
-
-
Serruys, P.W.1
Silber, S.2
Garg, S.3
Jan Van Geuns, R.4
Richardt, G.5
Buszman, P.6
Kelbaek, H.7
Van Boven, A.8
Hofma, S.9
Linke, A.10
Klauss, V.11
Wijns, W.12
Macaya, C.13
Garot, P.14
DiMario, C.15
Manoharan, G.16
Kornowki, R.17
Ischinger, T.18
Bartorelli, A.19
Ronden, J.20
Bressers, M.21
Gobbenns, P.22
Negoita, M.23
Van Leeuwen, F.24
Windecker, S.25
more..
|